This page is for clinic owners and marketing teams producing website content, social media posts, or paid ads targeting German patients. Germany has the strictest medical advertising rules in the EU — including a blanket ban on before/after photos that was expanded in 2025 to cover filler procedures and organic social posts. This guide shows you where the lines are and how to stay on the right side of them.
This page is especially relevant if you:
- advertise aesthetic, dental, dermatology, plastic surgery, or cosmetic services to German patients
- use German-language landing pages, Meta ads, or Google campaigns targeting Germany
- translate clinic content into German for the German market
- work with influencers or clinic brand ambassadors in Germany
- manage marketing for a clinic based outside Germany that attracts German patients
Germany’s Heilmittelwerbegesetz (HWG) is the single most enforced medical advertising law in the EU. The Wettbewerbszentrale — a civil law enforcement body — actively monitors clinic websites, social media, and advertising campaigns. Competitor clinics can also file complaints directly, which means violations get reported fast.
Most problems in German clinic marketing do not come from intentionally misleading content. They come from applying normal consumer marketing language to medical procedures. Phrases like “guaranteed results,” “pain-free,” “risk-free,” or before/after imagery are standard in beauty and wellness marketing — but under HWG they carry real legal risk, and some are an outright ban regardless of how accurate the underlying claim might be. The rules are different here, and most clinic marketing teams simply do not know where the lines are.
This page shows you the highest-risk phrases, what to replace them with, and where the grey areas are. It is a communication risk guide, not a legal compliance certification. Always verify specific cases with a qualified German legal professional.
The German Trigger Word List
These are the phrases most frequently flagged in German medical advertising reviews. If any appear on your website or in your ad copy, they are worth addressing first.
| What you wrote | Why it’s a problem | What to write instead |
|---|---|---|
| garantiert schmerzfrei / schmerzlos garantiert | Outcome guarantee — no medical procedure can guarantee a pain-free experience for every patient. One of the most commonly actioned phrases in Germany. | schmerzarm, schonend, mit modernen Betäubungsmethoden |
| 100% Erfolg / Erfolgsgarantie | Success guarantee — statistically impossible in medicine and explicitly prohibited as a false efficacy claim. | hohe Erfolgsrate (nur mit belegbarer Quellenangabe) |
| risikofrei / ohne Risiko | Risk elimination claim — all medical procedures carry some level of risk. This phrase is treated as a false safety assurance. | minimal-invasiv, sorgfältig geplant, mit umfassender Aufklärung |
| geheilt in einer Sitzung / sofort geheilt | Cure claim — implies a medical certainty that cannot be guaranteed for individual patients. | viele Patienten berichten von deutlicher Verbesserung nach einer Behandlung |
| beste Klinik / Nr. 1 Zahnarzt / führende Klinik Deutschlands | Unverifiable superlative — prohibited as a misleading claim if not objectively provable from a cited, current source. | spezialisiert auf [Bereich], erfahrenes Fachärzteteam |
| sofort schmerzfrei / sofortige Ergebnisse | Instant-result claim — implies a certainty of outcome across all patients, which qualifies as a false efficacy claim. | schnelle Linderung bei vielen Patienten möglich |
| Vorher-Nachher Bilder / before/after [any cosmetic procedure] | Before/after photos for cosmetic and plastic surgical procedures are banned outright under HWG — on websites, in paid ads, and on organic social posts. Expanded by BGH in 2025 to cover hyaluronic filler nose and jaw corrections. | Klinikumgebung, Teamfotos, oder neutrale Behandlungsillustration verwenden |
| Patientin Maria: “Endlich schmerzfrei!” (as ad content) | Patient testimonials used promotionally carry risk under HWG — particularly when they contain outcome or cure-type language. | Link zur Google-Unternehmensseite für Patientenbewertungen (passive Plattformanzeige) |
| Haarausfall? Jetzt Behandlungsanfrage stellen | Combining an indication or diagnosis prompt (“Haarausfall?”) with a booking CTA in a single funnel was confirmed as a HWG violation by the BGH in 2026. | Informationsgespräch zu Haartransplantation vereinbaren (without indication framing) |
5 Real-World Rewrites — Before & After
One higher-risk example and one lower-risk rewrite for each procedure type. Written as real marketing copy — not sanitised legal examples.
Problems: outcome guarantee (“garantiert schmerzfrei”), unverifiable superlative (“beste Klinik Münchens”) — both directly prohibited under HWG § 3.
Why it’s lower risk: “schonenden Verfahren” is a verifiable process description, not an outcome guarantee. No superlative. The booking CTA is a neutral service function, not tied to therapeutic claims.
Problems: outcome guarantee (“garantiert”), before/after imagery — the before/after ban applies to rhinoplasty and was explicitly confirmed to also cover hyaluronic filler nose corrections by BGH in 2025. Both violations are independent of each other.
Why it’s lower risk: Pricing retained as neutral factual information (PAngV-compliant total price basis). No guarantee. No before/after imagery — replaced with a consultation invitation.
Problems: risk elimination claim (“risikofrei”), pain-free guarantee (“ohne Schmerzen”), instant-result claim (“sofort sichtbare Ergebnisse”), before/after imagery — the 2025 BGH ruling confirmed the before/after ban explicitly covers hyaluronic filler procedures on Instagram organic posts, not just paid ads.
Why it’s lower risk: No false safety assurances, no outcome certainty, no before/after content. Outcome variability is stated explicitly. The Instagram before/after post is removed entirely — not replaced, removed.
Problems: outcome guarantee (“funktioniert garantiert”), patient testimonial with outcome language (“Endlich reine Haut!”) used promotionally — HWG § 11 restricts testimonials and case histories used in a misleading or promotional way.
Why it’s lower risk: “Zugelassene” and “aktuellen Standard” are verifiable facts. No guarantee. Testimonial removed from promotional context — if reviews are displayed, they belong on a passive third-party platform like Google Business, not featured on the clinic homepage.
Problems: no commercial disclosure (UWG transparency violation), before/after nose correction imagery (HWG § 11 ban, confirmed BGH 2025 for filler procedures and organic posts), discount code (promotional pricing in medical context — risk under § 3 / UWG). The clinic is liable for content it commissioned.
Why it’s lower risk: Clear disclosure. No before/after imagery. No discount code. Frames as personal consultation experience, not outcome proof. The clinic controls what the post says and it stays within the same boundaries as its own content.
High-Risk Content — What German Enforcement Has Actually Acted On
Some of these are explicit statutory prohibitions. Others are categories confirmed by BGH rulings or Wettbewerbszentrale enforcement. All are worth reviewing before your next campaign.
The risk: HWG § 3 prohibits all misleading medical advertising. This explicitly covers claims that suggest a treatment effect can be “expected with certainty,” that no side effects will occur, or that a procedure is risk-free. These are the highest-volume enforcement category in Germany.
In practice: “Garantiert schmerzfrei,” “100% Erfolg,” “risikofrei,” “geheilt in einer Sitzung,” “ohne Nebenwirkungen” — all prohibited regardless of how accurately the individual claim might apply to some patients.
The risk: HWG § 11 bans advertising for cosmetic/plastic surgical procedures using comparative before/after imagery. The BGH ruled in 2025 (I ZR 170/24) that this ban applies to hyaluronic filler procedures — not just surgical rhinoplasty — and to organic Instagram posts, not just paid advertising.
In practice: Any before/after image used to promote a cosmetic procedure — on the clinic website, in a Meta ad, or in an organic Instagram post — is in scope. This is not a grey area. Remove before/after content entirely from promotional contexts.
The risk: HWG § 11 Nr. 11 restricts the use of third-party statements — patient quotes, thank-you letters, endorsements — when used in a misleading or promotional way. Testimonials that contain outcome language (“finally pain-free,” “completely healed”) are particularly exposed.
In practice: Patient quotes featured on the homepage, pinned to social media, or used in ad copy are high-risk. Passive display of reviews on a third-party platform (Google Business, Jameda) is lower risk because the clinic is not actively curating them as advertising.
The risk: The BGH ruled in 2026 (I ZR 74/25) that combining a diagnosis or indication prompt (“Haarausfall?” / “Rückenschmerzen?”) with a booking or treatment request CTA in a single content flow creates a HWG § 10 violation. The indication framing turns a neutral booking function into regulated therapeutic advertising.
In practice: Clinic websites and landing pages that describe a symptom or condition alongside a “book a treatment consultation” button may need to be reviewed. Separating educational condition information from the booking CTA removes most of the risk.
The risk: Claims of being the “best,” “number one,” or “leading” clinic are treated as misleading commercial practices under HWG § 3 and UWG § 5 if they cannot be objectively proven from a cited, current, verifiable source.
In practice: “Beste Klinik Münchens,” “Deutschlands führende Haarklinik,” “Nr. 1 Zahnarzt” — all high-risk without a specific, linkable citation. A legitimately awarded ranking or certification can be mentioned, provided it is current and the source is named.
The risk: HWG § 11 Nr. 5 prohibits misleading visual depictions of body changes. Retouched, filtered, or otherwise enhanced result photographs used in promotional contexts are prohibited regardless of the before/after question.
In practice: Skin smoothing, colour correction, body reshaping in post-processing — if the image is used to show what a procedure can achieve, any undisclosed editing creates additional risk on top of the before/after prohibition.
The risk: HWG § 13 states that advertising by a company based outside Germany is only permissible if the company has appointed a responsible representative based in Germany. Cross-border campaigns targeting German consumers with German-language content may create exposure under this rule.
In practice: BGH confirmed in 2026 (I ZR 118/24) that HWG can apply to advertising by clinics based in other EU member states when that advertising targets German patients. If your clinic runs German-language ads or maintains a German-language website targeting Germany, this is worth reviewing with a qualified German legal professional before the next campaign.
The Grey Areas — Allowed Under Specific Conditions
These content types are not outright banned — but the details of how you handle them determine whether they create risk.
Allowed if: The statistic comes from a peer-reviewed, citable source. It is presented as population-level data (“in studies, X% of patients reported…”), not as an individual outcome guarantee. The source URL can be linked.
Crosses the line if: The statistic is presented as a promise to the individual reader (“100% Erfolg,” “95% unserer Patienten sind begeistert” without a verifiable source). Fabricated or un-cited statistics are treated as misleading efficacy claims.
Allowed if: Pricing is presented as transparent factual information, compliant with the PAngV requirement to show total prices (Gesamtpreis). “Rhinoplastik ab €799” used neutrally as an orientation figure is not per se prohibited.
Crosses the line if: Pricing is framed as a promotional discount, bargain, or limited-time offer. “Nur diese Woche: Botox ab €99” combines promotional urgency with a medical procedure — that framing increases HWG risk significantly.
Allowed if: The CTA is a standalone neutral service function — “Termin vereinbaren” or “Beratungsgespräch anfragen” sitting next to factual clinic information.
Crosses the line if: The CTA is part of a funnel that starts with a symptom or condition description. BGH 2026 (I ZR 74/25): symptom description + booking request in the same content flow = § 10 HWG violation. The fix is to separate educational condition content from the booking function.
Allowed if: Reviews are displayed passively via a third-party platform widget (Google Business profile, Jameda). The clinic does not select, curate, or editorially feature specific reviews on its own website.
Crosses the line if: The clinic actively republishes selected patient quotes on its homepage or in social content. BGH (Amazon case, 2020) confirmed that passively displayed platform reviews are different from actively featured testimonials — the latter carries § 11 Nr. 11 risk, especially when the quoted content contains outcome or cure language.
Allowed if: Exact official professional title (e.g., “Facharzt für Plastische und Ästhetische Chirurgie”), listed as factual information. Awards or certifications can be mentioned if current, verifiable, and linked to a source.
Crosses the line if: Credentials are used to imply superiority over competitors (“Deutschlands bester Facharzt”). The credential is the fact — the superlative framing is the risk.
Allowed if: Commercial relationship is clearly disclosed (#Werbung or equivalent, DSA-compliant). The influencer post does not contain claims the clinic itself could not legally make — no before/after imagery, no outcome guarantees, no discount codes. The clinic reviews the content before posting.
Crosses the line if: No disclosure tag. The post contains before/after content (§ 11 ban applies to content the clinic commissioned even if posted by a third party), or outcome guarantees. The Wettbewerbszentrale has proactively pursued undisclosed influencer marketing in healthcare since 2023.
The Cross-Border Trap for CEE Clinics
⚠ If your clinic is outside Germany and targeting German patients — read this
HWG § 13 explicitly addresses foreign advertisers: advertising by a company based outside Germany is only permissible if a responsible representative based in Germany has been appointed. This is not an interpretation — it is a specific statutory requirement. Any German-language advertising or website content targeting German consumers is potentially in scope, regardless of where the clinic is physically registered.
The BGH confirmed in 2026 (I ZR 118/24) that HWG can apply to advertising by clinics registered in other EU member states when that advertising targets German patients. The case involved Ireland-registered doctors — not a CEE fringe scenario. The matter was referred to the European Court of Justice, but the cross-border application of HWG to foreign-targeting content is already established in German case law.
Reference: German Rules Behind the Examples
For those who want the statutory detail behind the practical guidance above.
| Law | What it covers | Enforcing authority | Max penalty |
|---|---|---|---|
| HWG § 3 (Irreführungsverbot) | All misleading medical advertising — treatment guarantees, cure claims, risk-free claims, false efficacy claims, unverifiable success statistics | Wettbewerbszentrale (civil); Landesärztekammern (professional) | Criminal: imprisonment up to 1 year or fine (§ 14); Admin: €20,000–€50,000 (§ 15) |
| HWG § 11 Abs. 1 Satz 3 Nr. 1 | Before/after photos banned for cosmetic/plastic surgical procedures — applies to website, paid ads, AND organic social posts. Expanded to filler procedures by BGH I ZR 170/24 (2025). | Wettbewerbszentrale; civil courts | Cease-and-desist (Abmahnung); einstweilige Verfügung; damages |
| HWG § 11 Nr. 11 | Patient testimonials and third-party endorsements used in a misleading or promotional way — applies to drugs, treatments, and medical devices | Wettbewerbszentrale; civil courts | Abmahnung + damages |
| HWG § 10 | Advertising for prescription-only treatments / certain regulated indications to the general public — also relevant for indication + CTA funnel structures (BGH I ZR 74/25, 2026) | Wettbewerbszentrale; civil courts | Cease-and-desist; damages |
| HWG § 13 | Foreign companies advertising in Germany must appoint a responsible representative based in Germany | Wettbewerbszentrale; civil courts | Advertising may be treated as unlawful; injunction |
| UWG § 3a (in conjunction with HWG) | Unfair commercial practice — used to enforce HWG violations through civil courts; adds damages and injunction track | Wettbewerbszentrale; civil courts | Injunction; damages; Vertragsstrafe on repeat violation |
| Berufsordnung der Landesärztekammern | Professional advertising rules for licensed physicians — parallel to HWG, enforced by regional medical chambers | Landesärztekammern | Professional disciplinary action; licence suspension |
Key enforcement cases
BGH I ZR 170/24 “Hyaluron-Nasenkorrektur” (2025): An aesthetic practice advertised hyaluronic filler nose and jaw corrections with before/after content on its website and Instagram. The BGH ruled that a hyaluronic cannula correction is an “operative plastisch-chirurgischer Eingriff” under HWG § 1 Abs. 1 Nr. 2 Buchst. c, and that the before/after advertising ban under § 11 Abs. 1 Satz 3 Nr. 1 applies to organic Instagram posts — not just paid advertising. This is the most operationally significant ruling for aesthetic clinic social media content in recent years.
BGH I ZR 74/25 “Werbung für medizinisches Cannabis” (2026): A portal describing medical conditions for which cannabis treatment is available, combined with a treatment request CTA, was found to violate HWG § 10. The ruling established that combining indication/diagnosis-type language with a booking or treatment inquiry function creates a prohibited advertising structure — relevant for any clinic website that describes symptoms alongside a consultation booking button.
BGH I ZR 118/24 (2026 — ECJ referral): Case involving Ireland-registered doctors advertising online medical consultations to German patients. The BGH confirmed HWG can apply to the advertising, and referred the question of compatibility with EU free movement of services (Art. 56 AEUV) to the European Court of Justice. Outcome pending — but cross-border application of HWG to foreign-clinic advertising targeting Germany is already established at BGH level.
Legal disclaimer: This page provides general information about German medical advertising regulations for educational purposes only and does not constitute legal advice. Regulations change. Verify all compliance requirements with a qualified German legal professional before publishing any marketing materials. MedicalServiceFinder.com accepts no liability for decisions made based on this content.
Last updated: July 2026 | Primary sources: Heilmittelwerbegesetz (gesetze-im-internet.de/heilmwerbg); UWG (gesetze-im-internet.de/uwg_2004); BGH I ZR 170/24 (2025); BGH I ZR 74/25 (2026); BGH I ZR 118/24 (2026); Wettbewerbszentrale (wettbewerbszentrale.de); Bundesärztekammer Berufsordnung (bundesaerztekammer.de)
